Array BioPharma names vp of Regulatory Affairs and Quality Assurance

Howard Holden brings 25 years’ experience to the role

Array BioPharma, a US biopharmaceutical firm focused on developing drugs to treat cancer and inflammatory diseases, has appointed Howard Holden as vice president of regulatory affairs and quality assurance.

Holden has more than 25 years of experience in regulatory affairs and compliance in the pharmaceutical/biotechnology industry and will lead regulatory affairs and quality assurance for Array's pipeline of small molecule drugs.

From 2005 until 2012, Holden was senior vice president of regulatory affairs and compliance at Nereus Pharmaceuticals. Prior to this, he was vice president of regulatory affairs and compliance at Stressgen Biotechnologies and Ligand Pharmaceuticals; senior director at Parke-Davis/Warner-Lambert; director at Centocor and senior investigator at the National Cancer Institute.

Companies